Insulin affordability is an issue that has generated a lot of interest in St. Paul over the last several years. These life-saving drugs are critical for individuals living with diabetes. At both the federal and state levels, action has been taken to reduce the costs of these drugs.
Thankfully, the private sector is taking action to provide affordable access to insulin as well.
Just this week, Walmart announced the launch of the first-ever private brand analog insulin, which dramatically eases the access and affordability to diabetes care for customers. Available exclusively through Walmart’s private ReliOn brand, the new offering includes analog insulin vials ($72.88) and FlexPen ($85.88). According to Walmart, this offering will save customers between 58% to 75% off the cash price of branded analog insulin products.
The insulin is already available in Walmart pharmacies and will be available in Sam’s Club pharmacies in mid-July across the United States.
If you or someone you love has difficulty affording insulin, I encourage you to consult with your doctor and reach out to your local Walmart to see if this option would work for you.
Staying in Touch
Please do not hesitate to reach out to me to share your thoughts, questions, and concerns as it relates to state government. I can be reached at 651-296-4229 or via email at email@example.com.
Have a great day,